company background image
A066700 logo

Theragen EtexLtd KOSDAQ:A066700 Stock Report

Last Price

₩4.42k

Market Cap

₩141.5b

7D

0.6%

1Y

-7.3%

Updated

27 Mar, 2024

Data

Company Financials

Theragen Etex Co.,Ltd.

KOSDAQ:A066700 Stock Report

Market Cap: ₩141.5b

A066700 Stock Overview

Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products in Korea.

A066700 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Theragen Etex Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Theragen EtexLtd
Historical stock prices
Current Share Price₩4,420.00
52 Week High₩6,080.00
52 Week Low₩3,730.00
Beta0.48
1 Month Change3.51%
3 Month Change-1.12%
1 Year Change-7.34%
3 Year Change-50.23%
5 Year Change-58.88%
Change since IPO-28.36%

Recent News & Updates

Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals

Mar 27
Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals

Recent updates

Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals

Mar 27
Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals

Calculating The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Mar 21
Calculating The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Is Theragen EtexLtd (KOSDAQ:066700) A Risky Investment?

Feb 11
Is Theragen EtexLtd (KOSDAQ:066700) A Risky Investment?

Did Theragen EtexLtd's (KOSDAQ:066700) Share Price Deserve to Gain 36%?

Jan 16
Did Theragen EtexLtd's (KOSDAQ:066700) Share Price Deserve to Gain 36%?

A Look At The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Dec 21
A Look At The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

We're Not So Sure You Should Rely on Theragen EtexLtd's (KOSDAQ:066700) Statutory Earnings

Nov 23
We're Not So Sure You Should Rely on Theragen EtexLtd's (KOSDAQ:066700) Statutory Earnings

Shareholder Returns

A066700KR PharmaceuticalsKR Market
7D0.6%6.0%3.8%
1Y-7.3%28.8%13.0%

Return vs Industry: A066700 underperformed the KR Pharmaceuticals industry which returned 28.8% over the past year.

Return vs Market: A066700 underperformed the KR Market which returned 13% over the past year.

Price Volatility

Is A066700's price volatile compared to industry and market?
A066700 volatility
A066700 Average Weekly Movement3.8%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement5.3%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A066700 has not had significant price volatility in the past 3 months.

Volatility Over Time: A066700's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987201Jin-Yeob Gohttps://www.theragenetex.com

Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products in Korea. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company was formerly known as Theragen Co., Ltd.

Theragen Etex Co.,Ltd. Fundamentals Summary

How do Theragen EtexLtd's earnings and revenue compare to its market cap?
A066700 fundamental statistics
Market cap₩141.46b
Earnings (TTM)₩27.77b
Revenue (TTM)₩221.72b

5.1x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A066700 income statement (TTM)
Revenue₩221.72b
Cost of Revenue₩119.62b
Gross Profit₩102.10b
Other Expenses₩74.33b
Earnings₩27.77b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)867.79
Gross Margin46.05%
Net Profit Margin12.53%
Debt/Equity Ratio22.7%

How did A066700 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.